Lv1
40 积分 2024-06-02 加入
Clinical risk factors for recurrence of myelin oligodendrocyte glycoprotein antibody-associated disease
2个月前
已完结
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom
2个月前
已完结
Longitudinal evaluation of serum MOG-IgG titers in MOGAD after initiation of maintenance immunoglobulin: A case series
3个月前
已完结
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD)
3个月前
已完结
Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course
3个月前
已完结
Myelin oligodendrocyte glycoprotein antibody–associated disease with histopathologic features of primary CNS angiitis without demyelination: Case report and literature review
3个月前
已完结
Clinical analysis of myelin oligodendrocyte glycoprotein antibody-associated disease in a diverse cohort of children: A single-center observational study
3个月前
已完结
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
3个月前
已完结
Long-lasting pain and somatosensory disturbances in children with myelin oligodendrocyte glycoprotein antibody-associated disease
3个月前
已完结
Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease
3个月前
已完结
皖公网安备34019202002308
